Keywords: palatin, cleared, begin, trials, pt-141, technologies, initiate
Palatin cleared to begin trials of PT-141
Article | 29 June 2000
Palatin Technologies is to initiate clinical development of itserectile dysfunction nasal spray, PT-141, following a meeting with the US regulatory ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
